Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Middle East Pharmaceutical Industries Company SJSC
Income from Continuing Operations
Middle East Pharmaceutical Industries Company SJSC
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
|
Income from Continuing Operations
ď·Ľ65.8m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
SAU:2070
|
Income from Continuing Operations
ď·Ľ19.6m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-24%
|
|
|
J
|
Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
|
Income from Continuing Operations
ď·Ľ356.5m
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Middle East Pharmaceutical Industries Company SJSC
Glance View
Middle East Pharmaceutical Industries Company SJSC is a SA-based company operating in Pharmaceuticals industry. The company is headquartered in Riyadh, Riyadh and currently employs 335 full-time employees. The company went IPO on 2024-02-27. Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The firm develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
See Also
What is Middle East Pharmaceutical Industries Company SJSC's Income from Continuing Operations?
Income from Continuing Operations
65.8m
SAR
Based on the financial report for Dec 31, 2023, Middle East Pharmaceutical Industries Company SJSC's Income from Continuing Operations amounts to 65.8m SAR.
What is Middle East Pharmaceutical Industries Company SJSC's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
-3%
Over the last year, the Income from Continuing Operations growth was 11%. The average annual Income from Continuing Operations growth rates for Middle East Pharmaceutical Industries Company SJSC have been -3% over the past three years .
You don't have any saved screeners yet